Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. II. Structural elucidation.
- 1 January 1989
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 42 (5) , 667-673
- https://doi.org/10.7164/antibiotics.42.667
Abstract
Structures of new antibiotics, mureidomycins (MRD''s) A .apprx. D, were deduced from spectroscopic analyses and degradation studies. Two residues of m-tyrosine, one residue of 2-amino-3-N-methylaminobutyric acid (AMBA) and methionine are present in all components of the complex. Uracil is contained in MRD''s A and C, while dihydrouracil in MRD''s B and D. Methionine and m-tyrosine are connected through an ureiod bond, and uracil or dihydrouracil is linked to AMBA via enamine sugar moiety. In addition, MRD''s C and D contain a glycine residue at the N-terminal.This publication has 4 references indexed in Scilit:
- Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. III. Biological properties.The Journal of Antibiotics, 1989
- Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties.The Journal of Antibiotics, 1989
- A gas-liquid solid phase peptide and protein sequenator.Journal of Biological Chemistry, 1981
- Nonenzymatic Cleavage of Peptide Bonds: The Methionine Residues in Bovine Pancreatic RibonucleaseJournal of Biological Chemistry, 1962